Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia.
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
The objective of this study was to determine the effect of delayed therapy on morbidity and mortality associated with nosocomial Staphylococcus aureus bacteremia. The study included all episodes of S. aureus bacteremia that developed >2 days after hospital admission during 1999 to 2001. Classification and regression tree analysis (CART) was used to select the mortality breakpoint between early and delayed treatment. During the 25-month study period, 167 patients met the inclusion criteria. The breakpoint between delayed and early treatment derived using CART was 44.75 hours. On multivariate analysis, delayed treatment was found to be an independent predictor of infection-related mortality (odds ratio, 3.8; 95% confidence interval, 1.3-11.0; P=.01) and was associated with a longer hospital stay than was early treatment (20.2 days versus 14.3 days; P=.05). These findings support the notion that delay of therapy has deleterious effects on clinical outcomes, and efforts should be made to ensure that appropriate therapy is initiated promptly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among patients with documented MRSA infections, delays of > 24–48 h until antibiotic administration are associated with increased mortality in some studies [143–147], but not in others [148–154].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [145]
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,248
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“non-ICU), presence of a central venous catheter, receipt of total parenteral nutrition (TPN) or mechanical ventilation at the onset of SAB, source of bacteremia, and severity of illness at the onset of SAB (as calculated on the basis of the APACHE II score [17]).”
MethodCDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770 · cited 1×
“Only cases of SAB that occurred 2 days after hospital admission and that met the Centers for Disease Control and Prevention (CDC) criteria for bloodstream infection were included in the analysis [15].”
MethodIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 1×
“[11] reported that patients who received inappropriate empirical therapy for bloodstream infections in the ICU were at an almost 7-fold higher risk of mortality, compared with patients who received adequate antimicrobial therapy.”
Background(1995) · American Journal of Infection Control · doi:10.1016/0196-6553(95)90104-3 · Cited by 709
The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection
Leibovici, Shraga, Drucker, Konigsberger, Samra, Pitlik, & Pitlik (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00379.x · Cited by 685 · cited 1×
“4%) of 398 patients with SAB did not receive appropriate therapy 48 h after the first positive blood culture result was obtained [9].”
BackgroundBoyce, J. M., Opal, S. M., Chow, J. W., Zervos, M. J., Potter-Bynoe, G., Sherman, C. B., Romulo, R. L., Fortna, S., & Medeiros, A. A. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.5.1148-1153.1994 · Cited by 485 · cited 1×
“The widespread use of vancomycin to treat methicillinresistant Staphylococcus aureus (MRSA) infection has coincided with an increased incidence of vancomycinresistant enterococci (VRE) infections, and numerous studies have suggested an association between vancomycin use and the emergence of VRE [ 1-5].”
Background
Cited by
Items 401–500 of 650
Kleinhenz, M., Beesetty, P., Yang, C. W., Li, Z., & Montgomery, C. P. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02270-21 · Cited by 9
“This is consistent with strong evidence that early antibiotic therapy is critical for resolving systemic bacterial infections in humans (25, 26), although it is unclear whether rapid treatment is equally important in SSTI.”
ResultCEREBRAL ABSCESS ASSOCIATED WITH MENINGOCOCCAL MENINGITIS
Rothbaum, E., Nicholson, O., & Prince, A. S. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000227808.81951.74 · Cited by 9
Maury, É. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s5936 · Cited by 9
Wilson, J. W., Marshall, W. F., & Estes, L. L. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0415 · Cited by 9
Turner, R. B., Lalikian, K., Fry, M. M., Schwartz, J., Chan, D., & Won, R. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.07.003 · Cited by 9
“Specifically, delay in initiation of antibiotic therapy for treatment of Staphylococcus aureus BSI has been associated with higher mortality (10-12).”
Ramos, J. R., Ramírez, P., Concha, P., Salavert, M., Villarreal, E., Gordón, M., Frasquet, J., & Castellanos-Ortega, Á. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.03.007 · Cited by 9
Bouiller, K., Laborde, C., Aho, S., Hocquet, D., Péchinot, A., Moing, V. L., Bertrand, X., Piroth, L., & Chirouze, C. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.12.028 · Cited by 9
Heo, S. T., Peck, K. R., Ryu, S. Y., Kwon, K. T., Ko, K. S., Oh, W. S., Lee, N. Y., & Song, J. (2007) · Journal of Korean Medical Science · doi:10.3346/jkms.2007.22.4.682 · Cited by 9
Bloodstream Infection and Endocarditis
Seifert, H., & Wisplinghoff, H. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0019 · Cited by 9
Invasive Staphylococcus aureus infections
Jacobsson, G. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 9
Lee, Y. W., Kim, J.-H., Park, J. J., Park, H. J., Seo, H., & Kim, Y. K. (2025) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2025.105817 · Cited by 8
A simulation of loading doses for vancomycin continuous infusion regimens in intensive care
Šíma, M., Hronová, K., Hartinger, J. M., & Slanař, O. (2017) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2017.1328741 · Cited by 8
Complex case of COVID-19 and infective endocarditis
Alizadeh, K., Bucke, D., & Khan, S. N. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-242205 · Cited by 8
Salas, D. E., Minejima, E., Wu, J., Chong, F., Wang, J., She, R. C., Nieberg, P., & Wong‐Beringer, A. (2017) · PubMed · Cited by 8
Jorgensen, S. C. J., Lagnf, A. M., Bhatia, S., Singh, N. B., Shammout, L. K., Davis, S. L., & Rybak, M. J. (2019) · Infectious Diseases and Therapy · doi:10.1007/s40121-019-0238-1 · Cited by 8
Self-citationAplicación de árboles de decisión en la salud pública
Cardona, Á. M. S. (2012) · CES Salud Pública · doi:10.21615/2140 · Cited by 8
“Los hallazgos sugieren que el retraso en la terapia genera una efecto deletéreo en el resultado clínico y se deben hacer esfuerzos por iniciar la terapia apropiada prontamente (38).”
BackgroundFarfour, É., Larbi, A. G. S., Cardot, E., Limousin, L., Mathonnet, D., Cahen, P., Vasse, M., & Lesprit, P. (2018) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2018.11.015 · Cited by 8
New Strategies to Improve Outcomes in the Surgical Intensive Care Unit
Beilman, G. J. (2004) · Surgical Infections · doi:10.1089/sur.2004.5.289 · Cited by 8
Jeon, Y. L., Kim, M. H., Yang, H., Kang, S. Y., & Lee, W. I. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.09.010 · Cited by 8
Chen, Q., Zheng, Z., Shi, Q., Wu, H., Li, Y., & Zheng, C. (2022) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2022/8368578 · Cited by 7
“Appropriate antimicrobial therapy is defined as administering sensitive antibiotic therapy within 2 hours of the first culture of A. baumannii in the blood; administration of sensitive antibiotic therapy beyond 24 hours is considered delayed antibiotic therapy [19].”
Cheng, J., Li, Q., Zhang, G., Xu, H., Li, Y., Tian, X., Chen, D., & Luo, Z. (2022) · BMC Pediatrics · doi:10.1186/s12887-022-03622-6 · Cited by 7
“75 h for Staphylococcus aureus bacteremia [12].”
Manickam, K., Walkty, A. J., Lagacé-Wiens, P. R. S., Adam, H. J., Swan, B., McAdam, B., Pieroni, P., Alfa, M. J., & Karlowsky, J. A. (2013) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2013/201516 · Cited by 7
“Indeed, inadequate empirical antimicrobial therapy for S aureus bacteremia has been associated with increased mortality and prolonged time to defervescence in some, although not all, clinical studies (8-14).”
BackgroundLong-term survival outcome following Staphylococcus aureus bacteraemia
Ong, C. W., Roberts, J. L., & Collignon, P. (2013) · Healthcare Infection · doi:10.1071/hi12062 · Cited by 7
Toraño, M., Agbara, E. I., & Makanji, B. (2023) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxad276 · Cited by 7
Healthcare-Acquired Bacterial Infections
Lautenbach, E., & Abrutyn, E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09843-2_26 · Cited by 7
Consensus document on controversial issues for the treatment of hospital-associated pneumonia
Franzetti, F., Antonelli, M. M., Bassetti, M., Blasi, F., Langer, M., Scaglione, F., Nicastri, E., Lauria, F., Carosi, G., Moroni, M., et al. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.05.008 · Cited by 7
“The same results are obtained for Staphylococcus aureus respiratory(12) and bloodstream infections.(13)”
ResultTreatment of staphylococcal infections with cyclic lipopeptides
Eisenstein, B. I. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01921.x · Cited by 7
“Findings from a retrospective cohort analysis suggest that delayed treatment significantly increases the rate of mortality and duration of stay [35], while another study has shown that slight decreases in vancomycin susceptibility to MRSA (MIC ‡1.”
BackgroundWhat Is Inadequate Antibacterial Therapy?
Moellering, R. C. (2009) · Clinical Infectious Diseases · doi:10.1086/605556 · Cited by 7
Wong, S., Selby, P., & Reuter, S. E. (2024) · Pharmacology Research & Perspectives · doi:10.1002/prp2.1231 · Cited by 6
Comparison of methods for measuring antibiotic consumption in an intensive care unit
Olsen, M. H., Anhøj, J., Knudsen, J. D., Frimodt‐Møller, N., & Møller, K. (2018) · Apmis · doi:10.1111/apm.12909 · Cited by 6
“against that delayed antimicrobial therapy to patients with severe infection may be associated with an increased mortality (13, 14).”
BackgroundShin, S., Jung, H. J., Jeon, S., Park, Y.-J., Chae, J., & Yun, H. (2020) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s244836 · Cited by 6
Risk Factors and Patient Profile of Infective Endocarditis due to Gemella spp.
Kariyanna, P. T., Sutarjono, B., Ellanti, N. P., Jayarangaiah, A., Jayarangaiah, A., Chandrakumar, H. P., Tadayoni, A., Salifu, M. O., & McFarlane, I. M. (2020) · American Journal of Medical Case Reports · doi:10.12691/ajmcr-9-2-4 · Cited by 6
“Any delay in treatment will have negative effects on clinical outcomes in acute bacterial infectious diseases [6] and raises the risk of developing complications including infectious recurrences, cardiac surgery because of the valvular sequelae of the disease, and death [7].”
BackgroundLalueza, A., Morales‐Cartagena, A., Cháves, F., Juan, R. S., Laureiro, J., Lora‐Tamayo, J., López‐Medrano, F., Orellana, M. Á., & Aguado, J. M. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.06.025 · Cited by 6
Edgeworth, J., Ster, I. C., Wyncoll, D. L. A., Shankar‐Hari, M., & McKenzie, C. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku038 · Cited by 6
Peix, C., Vandenhende, M. A., Bonnet, F., Lacoste, D., Bernard, N., Youssef, J., Hessamfar, M., Pometan, J.-P., & Morlat, P. (2013) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.11.009 · Cited by 6
Jorgensen, S. C. J., Lagnf, A. M., Bhatia, S., & Rybak, M. J. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-03464-0 · Cited by 6
Self-citationWidodo, D. (2004) · Medical Journal of Indonesia · doi:10.13181/mji.v13i2.134 · Cited by 6
Lee, C., Chien, C., & Liu, J.-W. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/457435 · Cited by 6
Gracia, M., Martínez-Marín, C., Huelves, L., Giménez, M.-J., Aguilar, L., Carcas, A. J., Ponte, C., & Soriano, F. G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.996-1001.2005 · Cited by 6
“The results of experiments performed in order to evaluate the effect that early or delayed treatment may have on antibiotic efficacy indicate that early treatment is associated with a better outcome than delayed treatment, as observed in other experimental infection models (20) as well as in humans (15).”
ResultGómez, J., García‐Vázquez, E., Madrid, R. B., Canteras, M., Ruiz, J., Herrero, J. A., Baños, V., & Valdés, M. (2007) · Revista Clínica Española · doi:10.1157/13100196 · Cited by 6
Indication, intérêts et limites de la désescalade antibiotique en réanimation
LEROY, O., Boussekey, N., & Georges, H. (2006) · Réanimation · doi:10.1016/j.reaurg.2006.02.001 · Cited by 6
Pharmacodynamics of Vancomycin Against Coagulase‐Negative Staphylococci Bloodstream Infections
Harwood, K. H., Brusamarello, C. E., Wilkins, A. L., Zhu, X., Landersdorfer, C. B., & Gwee, A. (2025) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70180 · Cited by 5
Thrombocytopaenia during methicillin-sensitive Staphylococcus aureus bacteraemia
Forsblom, E., Tielinen, I., Ruotsalainen, E., & Järvinen, A. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2877-4 · Cited by 5
Presepsin: A Anew Marker for Early Diagnosis of Septicemia
EL-LATIF, M. D. A. O. A. H. H., & Atya, M. S. (2018) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2018.57512 · Cited by 5
Wade-Cummings, M., Mailman, J. F., Degelman, M. L., Phillips, C., & Vanstone, J. R. (2021) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v74i1.3039 · Cited by 5
Bellali, S., Haddad, G., Iwaza, R., Fontanini, A., Hisada, A., Ominami, Y., Raoult, D., & Khalil, J. B. (2022) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2022.100154 · Cited by 5
Chen, C., Lien, C., Huang, Y.-S., Ho, Y.-J., Lin, S.-Y., Fan, C., Chen, J., Huang, E. P., & Sung, C. (2023) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2023.04.002 · Cited by 5
Han, J., Bilker, W. B., Edelstein, P. H., Mascitti, K. B., & Lautenbach, E. (2012) · Epidemiology and Infection · doi:10.1017/s0950268812000295 · Cited by 5
“aureus [39, 40], awareness of a high likelihood of”
BackgroundNon availability of Cloxacillin, A Deterrent for Rational Antimicrobial Practice.
Srinivasaraghavan, R., & Dhandapany, G. (2016) · PubMed · Cited by 5
Delerue, T., Cordel, H., Delerue, T., Figoni, J., Dziri, S., Billard‐Pomares, T., Bouchaud, O., Carbonnelle, É., & Zahar, J. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03556-5 · Cited by 5
Ko, Y. J., Kook, J., & Lee, C. K. (2020) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2020.106065 · Cited by 5
Significant Publications on Infectious Diseases Pharmacotherapy in 2019
Hendrickson, J. A., Spitznogle, S. L., Gonzales-Luna, A. J., Babic, J. T., Britt, R. S., Knight, J. M., Pham, S. N., & McDaneld, P. M. (2020) · Journal of Pharmacy Practice · doi:10.1177/0897190020951348 · Cited by 5
“7% of patients, with median durations (IQR) of 78 days (42-99) and 71 days (43-94) in the IV and oral groups, respectively (p 1⁄4 0.”
BackgroundPresepsin as a Diagnostic and Prognostic Biomarker in Sepsis
Stankovic, S. D. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.107955 · Cited by 5
Impact of antimicrobial stewardship with the Xpert MRSA/SA BC assay at a tertiary hospital in Japan
Yamada, K., Imoto, W., Shibata, W., Kakuno, S., Nakaie, K., Myodo, Y., Takayama, N., Dobashi, A., Imai, M., Mitani, K., et al. (2023) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2023.03.021 · Cited by 5
Forsblom, E., Nurmi, A. M., Ruotsalainen, E., & Järvinen, A. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2563-y · Cited by 5
Actualización en Bacteriemia por Staphylococcus Aureus
Rivera, S. A. A., Barragán, D. A., & Jaimes, F. A. (2014) · Medicina U.P.B. · Cited by 5
The Utility of Rapid Microbiological and Molecular Techniques in Optimizing Antimicrobial Therapy
Eiland, E. H., Beyda, N. D., Han, J., Lindgren, W., Ward, R., English, T. M., Hassoun, A., & Hathcock, K. (2010) · SRX Pharmacology · doi:10.3814/2010/395215 · Cited by 5
“study as delayed therapy [17].”
MethodWilke, M. H., Hübner, C., & Kämmerer, W. (2020) · GMS infectious diseases · doi:10.3205/id000047 · Cited by 5
“Eine inadäquate Therapie ist mit erheblich höherer Sterblichkeit [1], [2], [3], [4], [5] und meist auch höheren Kosten verbunden [1], [6], [7], [8], [9].”
BackgroundOliveira, M. (2009) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 5
Antibiotika bei Sepsis und Multiorganversagen
Müller, E. E. (2006) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-006-0592-6 · Cited by 5
Lodise, T. P., Drusano, G. L., Lazariu, V., El-Fawal, N., Evans, A. M., Graffunder, E. M., Stellrecht, K. A., Mendes, R. E., Jones, R. N., Cosler, L. E., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku135 · Cited by 4
Self-citationBacteremic Outcomes in Older Adults: What Is Age Telling Us?
Crnich, C. J., & Zimmerman, D. R. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01943.x · Cited by 4
“In both situations, there is likely to be considerable delay in initiation of antimicrobial therapy with activity against causative microorganisms, which often results in considerable harm to the patient.(5,20,21) In the current study, rates of inappropriate antimicrobial therapy were greater with older age and greate…”
BackgroundKorshoj, L. E., & Nagpal, P. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b12568 · Cited by 4
Recent Advances in Direct Blood Culture Phenotypic Antimicrobial Susceptibility Testing
Garrett, E. M., & Bobenchik, A. M. (2022) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2022.11.005 · Cited by 4
Impact of a 20 mg/kg vancomycin loading dose on early AUC target attainment
Yang, S., Antoniello, A., & Smoke, S. M. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116355 · Cited by 4
Pharmacoeconomics of treatment with the newer anti-Gram-positive agents
Wang, L., & Barrett, J. F. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.7.885 · Cited by 4
“Many studies have been reported to measure the outcomes of antibiotic resistance [15-25].”
BackgroundGrossman, C., Keller, N., Bornstein, G., Ben‐Zvi, I., Koren‐Morag, N., & Rahav, G. (2016) · Journal of Chemotherapy · doi:10.1080/1120009x.2016.1182770 · Cited by 4
Bigseth, R. S., Sandholdt, H., Petersen, A., Østergaard, C., Benfield, T., & Thorlacius-Ussing, L. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01530-21 · Cited by 4
“As the time to appropriate antimicrobial therapy has an impact on the outcome of bacteremia, and in particular MS-SAB, it remains crucial to assess whether the effect of specific anti-staphylococcal EAT drugs differs significantly (5, 6, 28).”
BackgroundBilodeau, V., Huot, J., Perreault, C., Haraoui, L., Delorme, C., Poudrette, J., Marsot, A., & Crevier, B. (2022) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13818 · Cited by 4
Oh, J. K., Jung, J., Lee, S., Lee, S., Lee, E., Chang, E., Kang, C. K., Choe, P. G., Kim, Y.-J., Kim, N. J., et al. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131175 · Cited by 4
Li, Z., Yang, W., Ye, X., Yuan, Q., Zhao, J., Du, Z., Yu, J., Sun, Y., Wu, X., & Hu, J. (2023) · Neurocritical Care · doi:10.1007/s12028-023-01781-7 · Cited by 4
“Similar results were reported by Lodise et al., who found that the risk of mortality increased if antibiotic therapy was delayed by approximately 48 h in Staphylococcus aureus and Pseudomonas aeruginosa bloodstream infections [28, 29].”
Nosocomial, G. D. E. D. L. N., Leon, C. A., Mateos, J. M. G., Catalá, R., Vázquez, M., Rocha, L., & Nájera, M. D. (2009) · PharmacoEconomics Spanish Research Articles · doi:10.1007/bf03320853 · Cited by 4
Die Therapie der schweren Sepsis
Lorenz, J. (2009) · Pneumologie · doi:10.1055/s-0028-1119702 · Cited by 4
Health Care-Associated Pneumonia
Amin, A., & Kollef, M. H. (2010) · Hospital Practice · doi:10.3810/hp.2010.06.317 · Cited by 4
“Delayed initiation of appropriate antimicrobial therapy has also been shown to be associated with increased mortality in CAP(26) and bacteremia.(27,28) Recently, in a retrospective data analysis from patients with septic shock (N = 2731), Kumar et al(29) found that initiation of effective antimicrobial therapy within…”
BackgroundOptimizing Delivery of Care for Patients with MRSA Infection: Focus on Transitions of Care
McKinnon, P. S., Boening, A. J., & Amin, A. (2011) · Hospital Practice · doi:10.3810/hp.2011.04.391 · Cited by 4
Self-citationEmpirical therapy for serious Gram-positive infections: making the right choice
Segreti, J. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03061.x · Cited by 4
“To avoid delays in therapy, which can have significant consequences for treatment outcomes in serious infections [12], clinicians regularly make decisions on empirical therapy immediately on presentation, without the benefit of laboratory results, thereby making educated guesses as to the causative pathogens and their…”
BackgroundForsblom, E., Lepäntalo, A., Wartiovaara‐Kautto, U., Ruotsalainen, E., & Järvinen, A. (2019) · Apmis · doi:10.1111/apm.12955 · Cited by 4
“01) NS Previous endocarditis 3 (14) 0 — NS 1 (13) 2 (6) 2.”
Treatment of intra-abdominal and skin and soft tissue infections: The role of the glycylcyclines
Homer‐Vanniasinkam, S. (2006) · International Journal of Surgery · doi:10.1016/j.ijsu.2005.11.004 · Cited by 4
Antibiotika bei Sepsis und Multiorganversagen
Müller, E. E. (2007) · Steinkopff eBooks · doi:10.1007/978-3-7985-1729-5_5 · Cited by 4
Liu, H., Xu, T., Fu, H., Dai, B., & Xie, Y. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s509665 · Cited by 3
Inhibition of Staphylococcus aureus enterotoxin genes by using plant extracts
Mohammed, S. A., Al-ani, M. I. J., Mohammed, D. L., Salar, L. R., & Rasul, B. M. (2018) · Innovaciencia Facultad de Ciencias Exactas Físicas y Naturales · doi:10.15649/2346075x.469 · Cited by 3
An Electronic Algorithm to Identify Vancomycin-Associated Acute Kidney Injury
Cherian, J. P., Jones, G. F., Bachina, P., Helsel, T., Virk, Z., Lee, J. H., Fiawoo, S., Salinas, A. B., Dzintars, K., O’Shaughnessy, E. M., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad264 · Cited by 3
Community-Associated Methicillin-Resistant Staphylococcus aureus
Miller, L. G., & Eells, S. J. (2014) · ASM Press eBooks · doi:10.1128/9781555815592.ch12 · Cited by 3
Kanagasingham, K. C., Ho, K. M., & Robinson, J. O. (2020) · Anaesthesia and Intensive Care · doi:10.1177/0310057x20911925 · Cited by 3
Outcomes after Surgery among Patients Diagnosed with One or More Multi-Drug–Resistant Organisms
Gupta, A., Tennakoon, L., Spain, D. A., & Forrester, J. D. (2021) · Surgical Infections · doi:10.1089/sur.2020.400 · Cited by 3
“Delays in diagnosis of an MDRO can also prolong hospitalization [23].”
Ostrowski, J., Paterson, D. L., Lipman, J., & Udy, A. A. (2012) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1204000509 · Cited by 3
REPORT FROM THE AUSTRALIAN GROUP ON ANTIMICROBIAL RESISTANCE
Turnidge, J. D., Nimmo, G. R., Pearson, J. C., Gottlieb, T., & Collignon, P. (2007) · Cited by 3
Almangour, T. A., Alhifany, A. A., & Tabb, D. (2017) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2017/8648137 · Cited by 3
“tion and higher rates of mortality [1].”
Muthucumarana, K., Howson, P., Burrows, S., Swaminathan, S., & Irish, A. B. (2021) · Peritoneal Dialysis International · doi:10.1177/08968608211065871 · Cited by 3
Chandler, E. L., Wallace, K. L., Palavecino, E. L., Beardsley, J. R., Johnson, J. W., Luther, V. P., Ohl, C. A., & Williamson, J. (2022) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2022.26 · Cited by 3
Use of daptomycin for treatment ofStaphylococcus aureusinfections
Eisenstein, B. I. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.11.1523 · Cited by 3
“8-times higher in patients in whom appropriate antibiotic therapy was delayed [34] .”
BackgroundInfluentialMortalidad temprana en pacientes con bacteriemia extrahospitalaria
Ribes, E., Grau, S., Knobel, H., & Antonio, J. M.-D. (2005) · Medicina Clínica · doi:10.1157/13072044 · Cited by 3
Evaluation of MRSA Rapid Detection by Real-Time PCR Directly from Positive Blood Cultures
Kimura, T., Komori, T., Hirose, Y., Kurahashi, S., Yamada, Y., Kyotani, N., Yuasa, S.-I., & Fujita, N. (2010) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi.84.199 · Cited by 3
Becerra, M., & Néstor, Y. (2020) · UCrea (University of Cantabria) · Cited by 3
Infective Endocarditis and Antimicrobial Timing: A Case for Delay?
Stavropoulou, E., Ledergerber, B., Fourré, N., Zimmermann, V., Epprecht, J., Ianculescu, N., Monney, P. A., Τζίμας, Γ., Frank, M., Senn, L., et al. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf628 · Cited by 2
Staphylococcus aureus bacteremia in a tertiary care hospital in India
Abdulsalam, M. S., Gopalakrishnan, R., Suresh Kumar, D., Thirunarayan, M., Venkatesh, S., & Ramakrishnan, B. (2018) · Indian Journal of Medical Specialities · doi:10.1016/j.injms.2018.03.004 · Cited by 2
Infective endocarditis in 2018
Pelouch, R. (2018) · Intervenční a akutní kardiologie · doi:10.36290/kar.2018.041 · Cited by 2
“entů zásadní (1, 31, 32), může však být v úvodu obtížné.”
Impact of Appropriate Antibiotics within One Hour and Patients' Outcome: A Study and Review
Biswas, S. (2023) · Archives of Urology and Nephrology · doi:10.58489/2836-5828/005 · Cited by 2
Kim, T., Lee, S., Park, S. Y., Moon, S. M., Jung, J., Kim, M. J., Sung, H., Kim, M., Kim, S., Choi, S., et al. (2024) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-024-04790-2 · Cited by 2
“Treatment delay was defined as the initiation of appropriate antibiotic therapy occurring 3 or more days after the first positive blood culture [11, 13].”
Tratamiento con daptomicina en pacientes con bacteriemia
Llinares, P., & Iribarren, J. A. (2012) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(12)70067-8 · Cited by 2
Metadata
- Authors
- Lodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J.
- Affiliations
- Detroit Receiving Hospital (US)
- Eugene Applebaum College of Pharmacy and Health Sciences (US)
- Corresponding author
- McKinnon, Peggy S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-06-01
- Volume
- 36
- Issue
- 11
- Pages
- 1418-1423
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2102463930
- Cited by
- 604
- References
- 24
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 15 · 2023: 18 · 2022: 19 · 2021: 24 · 2020: 28 · 2019: 17 · 2018: 18 · 2017: 26 · 2016: 19 · 2015: 40 · 2014: 26 · 2013: 37 · 2012: 31
- FWCI
- 15.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- Staphylococcus aureus bacteremia, nosocomial infections, delayed antibiotic treatment, mortality, length of hospital stay, treatment timing, classification and regression trees
- MeSH terms
- Anti-Bacterial Agents, Cross Infection, Female, Humans, Male, Middle Aged, Retrospective Studies, Staphylococcal Infections, Staphylococcus aureus, Cohort Studies, Methicillin Resistance, Bacteremia, Treatment Outcome, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.